Cannabiz: The Business of Cannabis

Cannabiz co-founder Martin Lane and Legalise Cannabis Victoria MP David Ettershank discuss MardiGrass, the police response to 4/20, the state of relations with Premier Jacinta Allan’s Labor government and the funding of an off-road drug-driving trial in this week’s budget.

Cannabiz co-founder Martin Lane, chief correspondent Steve Jones and Legalise Cannabis NSW MP Jeremy Buckingham discuss the state’s adult-use inquiry and what it means for drug-law reform.

Cannabiz co-founder Martin Lane and Legalise Cannabis Victoria MP Rachel Payne discuss the findings from the latest National Drug Strategy Household Survey and what they mean for adult-use legalisation.

Legalise Cannabis Victoria MP David Ettershank joins Cannabiz co-founder Martin Lane and chief correspondent Steve Jones to discuss drug-driving reform, workplace drug testing and the lessons to be learned from the duck controversy in Victoria.

Legalise Cannabis Victoria MP Rachel Payne joins Cannabiz co-founder Martin Lane and chief correspondent Steve Jones to discuss the progress of the party's adult-use bill and the prospects for legalistion across Australia.

Standard Botanic founder and CEO Adam Benjamin joins Cannabiz co-founder Martin Lane and chief correspondent Steve Jones in the Green Room to discuss:

• The opportunities for Australian cultivators and how they can win in a global market
• What the reforms to TGO93 will mean for the industry in the next 12 months
• Whether legalising adult use would be good or bad for business
• The Australian and New Zealand presence at ICBC

Cannabiz co-founder Martin Lane and chief correspondent Steve Jones are joined by former FreshLeaf Analytics MD and industry consultant Cassandra Hunt to discuss consolidation, lobbying, cannabis tourism and the myth of the 'stoner sloth'.

Cannabiz editor-at-large Rhys Cohen joins co-founder Martin Lane to discuss his new role as senior corporate communications manager with Cann Group, plus:

The challenges facing Cann — and the wider industry — from a communications perspective.

The big predictions for this year and next.

What to look out for at the Australian Medicinal Cannabis Symposium this month.

Clever Leaves co-founder and chief regulatory officer Julian Wilches joins Cannabiz editor-at-large Rhys Cohen in The Green Room to discuss:

• operating in multiple markets with different regulatory frameworks
• what governments prioritise when changing regulations
• the importance of research
• global prescribing trends
• how Australia compares with other markets when it comes to patient acces

Last week, Colombia legalised the export of flower to international medicinal cannabis markets in a move described as the most significant change to the country’s regulations since 2017.

Oliver Zugel, founder and CEO of Colombian cultivator Foliumed, joins Cannabiz co-founder Martin Lane in the Green Room to discuss what the move might mean for the Australian market.

Bod Australia CEO Jo Patterson joins Cannabiz co-founder and chief innovation officer Kim McKay in the Green Room to discuss:

• Running a science-led business
• Differentiating your product portfolio
• Novel delivery formats
• Taking a start-up public
• Creating a culture where diversity can thrive
• And the future of work in a post-Covid world

FoliuMed founder and CEO Oliver Zugel joins Cannabiz co-founder Martin Lane in The Green Room to discuss:

• What lessons can be learned from other regulated industries
• How medical cannabis can move from niche to mass market in Australia
• Why over-the-counter CBD changes the rules of the game and what it will take to win
• Why local partners are the key to success

Cannabiz co-founders Martin Lane and Kim McKay are joined by editor-at-large Rhys Cohen to review the latest happenings in cannabis, including:

• The Dean of the Faculty of Pain Medicine’s anti-cannabis rant
• How the industry should respond to PR crises
• Kim’s vision for Women in Cannabis
• New York’s plans for legalisation

Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen are back with their review of the week in cannabis, including:

• What’s really going on with Australia’s flower shortage
• New Zealand’s latest medicinal cannabis framework delay
• The launch of Women in Cannabis
• And what to look out for at this week’s ACannabis EVOLVE conference

Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen are back with their review of the week in cannabis, including:

• The Greens’ contribution to the legalisation debate
• Cann Group’s shot in the arm
• Martin’s Princess Diana moment
• What to expect from our free webinar on the Narcotic Drugs Amendment Bill
• And the unelectability of celebrity chef Pete Evans

Medlab Clinical managing director Dr Sean Hall joins Cannabiz co-founder Martin Lane in The Green Room to discuss:

• The next steps for Medlab’s cancer-related pain treatment NanaBis.
• The company’s plan to expand Stateside.
• The benefits of the drug approval pathway versus over-the-counter products.
• The industry’s duty of care to patients and their families when raising expectations about product availability.
• And where the industry will be in 12 months’ time.

Cannabiz co-founder Martin Lane and editor-at-large Rhys Cohen are back with their take on the week’s cannabis news, including:

• Who to blame for this week’s media coverage of over-the-counter CBD
• What the Narcotic Drugs Amendment Bill means for the Australian industry
• Where the next US$7.2 billion cannabis company will come from
• And what David Beckham could learn from the Cannabiz team’s skincare regime

In this episode of Cannabiz: The Business of Cannabis, the team discuss New Zealand's election results and what it all means for the upcoming results of the cannabis referendum.

We also ask if drug-driving laws are set to change in Australia after the Victorian state government said it will explore new legislation to treat medical cannabis like any other medicine when it comes to driving.

Cannabiz digital content producer Emma Castle spoke to former undercover Queensland cop turned crime writer Keith Banks about Victoria’s drug-driving plans and much more besides.

In the second ever episode of Cannabiz: The Business of Cannabis, we discuss ex-magistrate David Heilpern's call for Australia's drug-driving laws to change, the issue with imported cannabis products, and the latest big deal between Montu Group and Jupiter Health.

We chat to Montu managing director Chris Strauch about the deal, and discuss why now is the time for a shift towards better patient access, the best way to educate GPs, and how Australia became the fastest-growing cannabis market in the world.

And finally, we consider if the Cannabiz editorial team could be in the running to win the first-ever cannabis business reality TV show: Who Wants To Be A Marijuana Millionaire? Spoiler alert: we're not.